return equiti ttm
teleflex teleflex end-of-quart one-off continu hamper
report second-quart result includ disappoint organ constant-
currenc revenu growth result beat estim bottom line driven
oper expens control lower incom tax specif revenu million
report organ day adjust constant-curr
basiswel model consensu manag attribut
miss lower-than-anticip sale ez-io municip distributor order time
last day june supplier constraint relat fire one compani
supplier surgic product total amount somewher around million
revenu materi quarter hope one-off item given
distributor ez-io sale first week juli show nice bounc back
regardless type predict reliabl win investor
see one-off occur much frequenc
despit lacklust result quarter first-half organ constant-curr
growth manag reiter intent achiev full-year guidanc
reiter constant-curr revenu target organ constant-curr revenu
guidanc remain inorgan revenu growth manag
laid bridg first-half growth midpoint full-year organ
constant-curr requir growth rate second half year
specif team think growth come neotract vascular
solut ship day impact surgic product line exit
base busi growth driver appear shift bit
reflect greater organ contribut neotract fourth quarter caution unless
bucket come team meet low end target
model low end rang reflect concern base busi growth
fortun second-quart earn came better model earn per
share versu model upsid target came incom tax
oper expens control net item off-set sale
volum headwind weaker gross margin go forward manag
re-affirmed profit target even face increment foreign exchang view
posit view remain focus compani abil drive margin
earn expans non-revenu depend mean key stori
valuat support
diversifi provid primarili single-us medic devic use treatment acut life-
threaten ill compani segment includ vascular access surgic anesthesia/respiratori
pleas refer import disclosur page analyst certif page
william blair affili seek busi compani cover research report
result investor awar firm may conflict interest could affect object
report report intend provid person invest advic opinion recommend
herein take account individu client circumst object need intend
recommend particular secur financi instrument strategi particular client recipi
report must make independ decis regard secur financi instrument mention
view quarter yet anoth wake-up call around tent day
provid predict quarterli guidanc minim volatil around earn appear last
sever quarter caught guard one-off type event caus compani meet organ top-
line expect fulli understand ebb flow busi time issu real
certainli risk oper multi-national busi time come believ team need
deliv commit provid better pictur expect quarterli basi
team place done number posit thing busi includ turn stori one focus
margin earn expans last sever quarter fallen short abil truli forecast deliv
revenu growth therefor urg team buckl achiev goal rethink quarterli messag
believ focus annual target rather quarter could help reduc volatil stock around earn
frustrat thursday result think stori broken bright spot continu come
brilliant acquisit neotract growth vascular solut manag abil deliv meaning
oper margin expans wrote follow compani analyst day thesi reli team abil drive
roughli midteen earn growth next year non-revenu depend oper margin expans
opportun addit fuel earn power futur thesi remain intact therefor
reiter outperform rate
stock maintain outperform rate base view abil hit growth target second-
quarter pro forma growth along basi point oper margin expans
yield ep number around repres midteen earn compound-annual-growth-rate accret deal
consumm aggress debt paydown occur maximum benefit recent announc restructur
thu stock trade time updat ep target view margin expans
stori opportun inorgan accret next coupl year scarciti devic asset cap rang keep
attract name
neotract revenu quarter million growth therefor manag revis
revenu growth target call year-over-year growth excess
number would higher manufactur issu quarter effort drive addit
margin asset team initi manufactur improv product swap new mold
compon deliveri devic urolift made new mold sent urologist
devic would releas implant fire therefor manag immedi withdrew product made
new mold swap origin one use manufactur slight hiccup manufactur
caus million headwind revenu expect recoup third quarter addit
result addit cost million manag believ basi point team rework
new mold cost associ hiccup addit charg third
quarter though guidanc alreadi assum overli concern issu commend way
team handl situat overal neotract continu oper beast mode save day
time
distributor commentari manag note order come back first week juli
continu struggl team combat predict issu like seen last
quarter ask manag note chang interact distributor though result indic
visibl limit move forward one-third product go distributor
prior year help minim disrupt regardless believ someth need chang
team need gain better understand dynam play
tariff much like multin list bit tariff risk manag call
roughli total exposur relat product come china estim includ tariff
may impos finish good may impact price see major impact think
abl absorb impact still hit guidanc current talk becom realiti
quarter reviewcurr actualcurr estimateprior year quarter thousand unless revenu estim fx total revenu gross bp bp oper oper bp income/ expens nmearn incom tax effect bp incom nci- net incom bp dilut share ep consensu estim currentrevenu earn per sourc william blair compani estim compani report factset consensusfav/ unfav variancey/i chang william blair
updat estim manag refin foreign exchang guidanc second-half organ -currenc
ramp fourth quarter estim littl chang top bottom line remain well
highlight model includ
third-quart organ constant-curr day adjust growth
fourth-quart organ constant-curr day adjust growth
full-year organ constant-curr growth
full year neotract revenu million
project organ constant-curr revenu earn growth
bridg estim actualep bridg prior yearep growthep growthour prior favorable/ unfavor varianc favorable/ unfavor varianc sale sale gross gross oper oper incom incom incom non-controlling interest- incom non-controlling interest- share share current william blair
model chang thousand unless notedprevi estimatechangecurr estimatecurr estimatetot revenu fx total revenu gross bp oper oper bp income/ expens earn incom effect tax bp incom nci net incom bp share ep sourc william blair compani estim compani reportsconsensu estim revenu earn per sourc import disclosur
